|
🐜
|
Transcriptional mediators of treatment resistance in lethal prostate cancer
26 auth.
M. X. He,
Michael S. Cuoco,
Jett Crowdis,
Alice Bosma-Moody,
Zhenwei Zhang,
K. Bi,
Abhay Kanodia,
Mei-ju Su,
Christopher Rodman,
L. Dellostritto,
Parin Shah,
K. Burke,
B. Izar,
Z. Bakouny,
Alok K. Tewari,
...
David Liu,
S. Camp,
N. Vokes,
Jihye Park,
S. Vigneau,
L. Fong,
O. Rozenblatt-Rosen,
A. Regev,
Asaf Rotem,
M. Taplin,
E. V. Van Allen
|
6 |
2020 |
6
🐜
|
|
🐜
|
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
53 auth.
Z. Bakouny,
D. Braun,
S. Shukla,
Wenting Pan,
Xin Gao,
Yue Hou,
A. Flaifel,
Stephen Tang,
Alice Bosma-Moody,
M. X. He,
N. Vokes,
J. Nyman,
W. Xie,
A. Nassar,
Sarah Abou Alaiwi,
...
R. Flippot,
G. Bouchard,
J. Steinharter,
P. Nuzzo,
M. Ficial,
M. Sant'angelo,
J. Forman,
Jacob E. Berchuck,
Shaan Dudani,
K. Bi,
Jihye Park,
S. Camp,
Maura Sticco-Ivins,
L. Hirsch,
S. Baca,
M. Wind-Rotolo,
P. Ross-Macdonald,
Maxine Sun,
G. Lee,
Steven L. Chang,
Xiao X. Wei,
B. McGregor,
L. Harshman,
G. Genovese,
L. Ellis,
M. Pomerantz,
M. Hirsch,
M. Freedman,
M. Atkins,
Catherine J. Wu,
T. Ho,
W. Linehan,
D. McDermott,
D. Heng,
S. Viswanathan,
S. Signoretti,
E. V. Van Allen,
T. Choueiri
|
6 |
2021 |
6
🐜
|
|
🐜
|
Mutational footprint of platinum chemotherapy in a secondary thyroid cancer
21 auth.
Julia Schiantarelli,
T. Pappa,
J. Conway,
Jett Crowdis,
B. Reardon,
Felix Dietlein,
Julian Huang,
Darren Stanizzi,
Evan Carey,
Alice Bosma-Moody,
...
A. Imamovic,
Seunghun Han,
S. Camp,
Eric Kofman,
Erin Shannon,
J. Barletta,
M. X. He,
David Liu,
Jihye Park,
J. Lorch,
E. V. Van Allen
|
2 |
2022 |
2
🐜
|
|
🐜
|
Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma.
15 auth.
Julia Schiantarelli,
Mouadh Benamar,
Jihye Park,
Haley E. Sax,
Giacomo Oliveira,
Alice Bosma-Moody,
Katie M. Campbell,
David Liu,
Douglas B. Johnson,
S. Rodig,
...
Catherine J. Wu,
F. S. Hodi,
Antoni Ribas,
Eliezer R. Van Allen,
Rizwan Haq
|
0 |
2025 |
0
🐜
|
|
🐜
|
Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors
56 auth.
Z. Bakouny,
D. Braun,
S. Shukla,
Wenting Pan,
Xinrong Gao,
Yue Hou,
A. Flaifel,
Stephen Tang,
Alice Bosma-Moody,
M. X. He,
N. Vokes,
J. Nyman,
W. Xie,
A. Nassar,
S. A. Alaiwi,
...
R. Flippot,
G. Bouchard,
J. Steinharter,
P. Nuzzo,
M. Ficial,
M. Sant'angelo,
J. Forman,
J. Forman,
Jacob E. Berchuck,
Shaan Dudani,
K. Bi,
Jihye Park,
S. Camp,
Maura Sticco-Ivins,
L. Hirsch,
M. Wind-Rotolo,
P. Ross-Macdonald,
Maxine Sun,
G. Lee,
Steven L. Chang,
Xiao X. Wei,
B. McGregor,
L. Harshman,
G. Genovese,
L. Ellis,
L. Ellis,
M. Pomerantz,
M. Hirsch,
M. Freedman,
M. Atkins,
Catherine J. Wu,
Catherine J. Wu,
T. Ho,
W. Linehan,
D. McDermott,
D. Heng,
S. Viswanathan,
S. Signoretti,
S. Signoretti,
E. Allen,
T. Choueiri
|
0 |
2020 |
0
🐜
|
